Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease

Table 5

Time until relapses according to mRS scores after TPE and 90 days after TPE.

Relapses <90 days after TPE				Relapses >90 days after TPE
mRS score after TPE	Patients with the score (n = 185)	Patients who relapsed, n (%)	Time until relapse (days)	mRS score 90 days after TPE	Patients with the score (n = 104)	Patients who relapsed, n (%)	Time until relapse (days)
5	19	1 (5,55)	71	5	1	1 (100)	195
4	27	2 (7,4)	34,5 (26-43)	4	15	4 (26.7%)	139,5 (115,25-166)
3	51	8 (15,7)	12,5 (4,25–47,75)	3	30	7 (23%)	151 (29,35)
2	42	7 (16,7)	50 (30,04)	2	28	5 (17,86%)	160,2 (69,79)
1	28	6 (22,2)	24,6 (15,9)	1	22	5 (22,7%)	201,2 (94,73)
0	18	4 (22,2)	16,5 (4,75–56,75)	0	8	1 (12,5%)	272

Mean (SD); Median (IQR). mRS, modified Rankin Scale.